文献速递衰弱、肌少症与跌倒老年综合评估老年慢病共病管理

神经肌肉衰老轨迹研究(TRAJECTOR-AGE临床试验):研究依据与方法学方案

The Trajectories of Neuromuscular Aging (TRAJECTOR-AGE Clinical Trial): Study Rationale and Methodological Protocol.
PubMed 文献 · J Am Geriatr Soc · 2025-07-12

TRAJECTOR-AGE是一项在意大利多中心开展的前瞻性纵向队列研究,为期2年,招募社区居住、身体和认知健康的中年(50-60岁)和老年(>70岁)成人。研究每6个月进行综合临床与生理评估,每年采集生物样本,结合影像与分子数据,旨在阐明神经肌肉衰退的病理生理机制并识别早期生物标志物。

要点

  • 纳入社区健康中年(50-60岁)和老年(>70岁)成人,排除糖尿病、神经疾病、严重心衰等共病者。
  • 每6个月评估老年状态、体成分、心血管功能及神经肌肉表现,每年行股四头肌超声和MRI。
  • 每年采集血、尿及股外侧肌活检,评估炎症、代谢和神经肌肉生物标志物。

核心结论

  • 通过整合临床、功能和分子数据,TRAJECTOR-AGE研究旨在阐明神经肌肉衰退的病理生理机制,捕捉个体间变异,并探索习惯性体力活动对衰老轨迹的影响。

研究设计与样本

  • TRAJECTOR-AGE为前瞻性纵向队列研究,在意大利多中心开展,为期2年。
  • 招募社区居住、身体和认知健康的中年(50-60岁)和老年(>70岁)成人,排除具有显著共病(如糖尿病、神经疾病、严重心衰)的个体。

关键数值与推荐

  • 参与者每6个月接受综合临床和生理评估,包括老年状态、体成分、心血管功能和神经肌肉表现。
  • 影像学包括定期股四头肌超声和每年多参数MRI,以评估肌肉体积和脂肪浸润。
  • 每年采集血、尿和股外侧肌活检样本,以评估炎症、代谢和神经肌肉生物标志物。

临床怎么用

  • 该多维方法可能有助于早期识别功能衰退风险个体,并为制定针对性预防或治疗干预以促进独立和健康衰老提供信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To examine the structural, metabolic, and functional trajectories of neuromuscular decline in aging and identify key mechanisms and early biomarkers to guide interventions preserving function and independence. DESIGN: The TRAJECTOR-AGE project is a prospective, longitudinal cohort study conducted over 2 years across multiple centers in Italy. SETTING AND PARTICIPANTS: Community-dwelling, physically and cognitively healthy middle-aged (50-60 years) and older (> 70 years) adults are recruited. Individuals with significant comorbidities (e.g., diabetes, neurological disorders, severe heart failure) are excluded. MEASUREMENTS: Participants undergo comprehensive clinical and physiological evaluations every 6 months, including assessments of geriatric status, body composition, cardiovascular function, and neuromuscular performance. Imaging includes periodic quadriceps ultrasound and annual multiparametric MRI to assess muscle volume and fat infiltration. Biological samples (blood, urine and Vastus lateralis muscle biopsy) are collected yearly to evaluate inflammatory, metabolic, and neuromuscular biomarkers. EXPECTED RESULTS: By integrating clinical, functional, and molecular data over time, the TRAJECTOR-AGE study aims to clarify the pathophysiological mechanisms underlying neuromuscular decline, capture inter-individual variability, and explore the influence of habitual physical activity on aging trajectories. CONCLUSIONS: This multidimensional approach may enable earlier identification of individuals at risk for functional decline and inform the development of targeted preventive or therapeutic interventions to promote independence and healthy aging.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Lauretani F, Maggio M, Pilotto AM, et al. The Trajectories of Neuromuscular Aging (TRAJECTOR-AGE Clinical Trial): Study Rationale and Methodological Protocol. J Am Geriatr Soc. 2025. PMID: 40650622. doi:10.1111/jgs.70005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。